Brain organoids promise medical breakthroughs but demand ethical governance to prevent exploitation and unintended consequences

Indigenous frameworks view human tissue as sacred and communal, not as a resource for extraction or commodification. The creation of brain organoids challenges traditional understandings of personhood and the soul, as many cultures believe consciousness is not confined to the brain but is a holistic property of the being. The lack of consultation with Indigenous communities in tissue sourcing echoes historical patterns of biopiracy, where knowledge and materials were taken without consent or reciprocity. These perspectives demand a redefinition of 'ethical' research that centers relational accountability rather than individual consent forms.

The development of brain organoids is rooted in a history of exploitative medical research, from the Tuskegee syphilis experiments to the unethical use of Henrietta Lacks' cells. Colonial-era practices of tissue collection in Africa and Asia laid the groundwork for today's biotech industry, where Global South populations remain sources of cheap biological material. The patenting of human genes and tissues, exemplified by the 1980 Diamond v. Chakrabarty case, established the legal framework for the commercialization of life. These precedents reveal a pattern of prioritizing scientific progress over human dignity, which continues in the organoid field.

Cross-culturally, the ethical concerns around brain organoids reveal tensions between Western biomedical individualism and communal or spiritual worldviews. In Japan, the concept of 'wa' (harmony) extends to biological materials, raising questions about the disruption of natural order through artificial creation of brain tissue. Latin American bioethicists emphasize the principle of 'buen vivir,' which prioritizes collective well-being over technological advancement. These diverse frameworks highlight the need for pluralistic governance models that incorporate non-Western ethical perspectives.

Scientifically, brain organoids offer unprecedented insights into human brain development and disease modeling, but their creation raises unresolved questions about consciousness and sentience. Studies show that organoids can exhibit electrical activity patterns resembling those of preterm infants, complicating ethical debates about their moral status. The lack of standardized protocols for assessing consciousness in organoids creates a regulatory vacuum that risks both under- and over-regulation. Additionally, the reproducibility crisis in biomedical research underscores the need for rigorous, transparent methodologies in organoid studies.

Artistic and spiritual traditions have long grappled with the boundaries between life and non-life, as seen in myths of golems, Frankenstein's monster, or the Hindu concept of 'prana' (life force). Contemporary artists like Eduardo Kac have explored the ethical implications of bioart, such as his 'GFP Bunny,' which challenges notions of purity and contamination. Spiritual frameworks, including Buddhist teachings on interdependence, question the ethics of creating artificial life forms that may suffer or experience consciousness. These creative and spiritual perspectives invite a more nuanced dialogue about the moral dimensions of organoid research.

Future scenarios for brain organoids range from utopian visions of curing neurodegenerative diseases to dystopian fears of creating sentient beings for exploitation. Modeling suggests that without equitable access frameworks, organoid technologies could deepen global health disparities, as wealthy nations patent treatments derived from Global South tissue. The potential for organoids to be used in human enhancement or military applications (e.g., brain-computer interfaces) raises questions about long-term societal impacts. Scenario planning must include input from ethicists, policymakers, and marginalized communities to avoid unintended consequences.

Marginalized communities, including people with disabilities, racial minorities, and Global South populations, are often excluded from ethical debates about organoid research despite bearing disproportionate risks. Disability rights advocates argue that organoid research could lead to eugenic practices, such as selecting against certain genetic traits. Racial minorities have historically been subjected to unethical medical experimentation, making them skeptical of promises of 'benefit' from organoid technologies. Their inclusion in governance structures is essential to prevent the repetition of past injustices.